MedPath

Transtibial Pull Out Method Versus Suture Anchor Method for Meniscus Extrusion

Not Applicable
Recruiting
Conditions
Meniscal Extrusion
Meniscus Injury
Registration Number
NCT06906783
Lead Sponsor
Ataturk University
Brief Summary

The concept of meniscal extrusion has recently been recognized as an important pathological condition associated with meniscal dysfunction. Meniscal extrusion is the medial or lateral displacement of the meniscus beyond the edges of the tibial plateau. Some meniscal extrusions are physiologic, but large degrees of extrusion are thought to be pathologic.

Meniscal extrusion can vary in extent from minimal physiological extrusion to extrusions exceeding 10 mm. The generally accepted threshold value is considered to be 3 mm.

To date, the gold standard for measuring meniscal extrusion is T2-weighted MRI. MRI is valuable not only due to its ability to define other meniscal or knee pathologies but also because it provides good sensitivity and specificity.

Surgical treatment of meniscal extrusion is preferred in young, active, symptomatic patients and individuals with acute injuries. The treatment approach may vary depending on the underlying cause. One of these methods is centralization surgery, which aims to achieve the anatomical reduction of the extruded meniscus.

The aim of this study is to compare the functional outcomes of transtibial pull-out and suture anchor techniques used in centralization surgery and to contribute to standardization.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
46
Inclusion Criteria
  • Presence of meniscal extrusion greater than 3 mm on MRI scans
  • Symptomatic complaints in the knee with extrusion
Exclusion Criteria
  • Malalignment greater than 5 degrees
  • Presence of Kellgren-Lawrence grade 3-4 osteoarthritis

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Change in the amount of meniscus extrusion in MR images.From enrollment to the end of treatment at 12 months

determine the change in the amount of meniscus extrusion in preoperative and postoperative 12th month MR images.

Secondary Outcome Measures
NameTimeMethod
Lysholm scoreFrom enrollment to the end of treatment at 3, 6 and 12 months.

The Lysholm score is a 100-point scoring system for examining a patient's knee-specific symptoms including mechanical locking, instability, pain, swelling, stair climbing, and squatting.

Tegner activity scoreFrom enrollment to the end of treatment at 3, 6 and 12 months.

The scale is numbered on a "0-10" format, with 10 being international soccer, and one being a person who is disabled from knee issues.

International Knee Documentation Committee (IKDC) ScoreFrom enrollment to the end of treatment at 3, 6 and 12 months.

The IKDC is a patient-completed tool, which contains sections on knee symptoms (7 items), function (2 items), and sports activities (2 items). Scores range from 0 points (lowest level of function or highest level of symptoms) to 100 points (highest level of function and lowest level of symptoms).

Trial Locations

Locations (1)

Ataturk University Hospital

🇹🇷

Erzurum, Yakutiye, Turkey

© Copyright 2025. All Rights Reserved by MedPath